Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Myriad Genetics enters into agreement with Rockefeller University for cancer gene research

May 8, 1998

Exemestane now under regulatory review, P&U reports

May 8, 1998

Nikken initiates development of new anticancer agent

May 7, 1998

Agouron's MMP inhibitor AG-3340 enters phase II/III trials

May 7, 1998

Ribozyme's anticancer drug Angiozyme shows promise in preclinical trials

May 7, 1998

Genset announces discovery of novel prostate cancer-related gene

May 7, 1998

Anticancer activity of mEGP has been reported

May 7, 1998

BE-56980: new antitumor agent discovered by Banyu

May 6, 1998

Apoptosis-inducing iminodiacetic acid derivatives described by Mitsui Toatsu

May 6, 1998

GenVec, Fuso collaborate on cancer gene therapies

May 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.